Inotiv, inc. announces debt financing and completion of acquisitions of histotox labs, inc. and bolder biopath, inc.

West lafayette, ind., april 30, 2021 (globe newswire) -- inotiv, inc. (nasdaq:notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced that the company has secured $28.0 million in debt financing from first internet bank of indiana and completed the previously-announced acquisition of substantially all of the assets of histotox labs, inc. (“histotox labs”) and the acquisition by merger of bolder biopath, inc. (“bolder biopath”), effective april 30, 2021.
NOTV Ratings Summary
NOTV Quant Ranking